N-(2,6-Dimethylphenyl)-4-(4-methylphenyl)-1,3-thiazol-2-amine

Catalog No. :
ACZZEG082
CAS No. :
730950-31-9
Molecular Formula :
C18H18N2S
Molecular Weight :
294.42

IUPAC Name:N-(2,6-dimethylphenyl)-4-(p-tolyl)thiazol-2-amine

N-(2,6-Dimethylphenyl)-4-(4-methylphenyl)-1,3-thiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$70.00Login to see priceInquiryInquiry
250mg95%$132.00Login to see priceInquiryInquiry
1g95%$338.00Login to see priceInquiryInquiry
5g95%$949.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2,6-Dimethylphenyl)-4-(4-methylphenyl)-1,3-thiazol-2-amine
IUPAC NameN-(2,6-dimethylphenyl)-4-(p-tolyl)thiazol-2-amine
MDL No.MFCD04621567
Molecular FormulaC18H18N2S
Molecular Weight294.42
SMILESCC1=CC=C(C2=CSC(NC3=C(C)C=CC=C3C)=N2)C=C1
InChI KeyYYTSQSQEVHDBBY-UHFFFAOYSA-N
Synonym2-Thiazolamine, N-(2,6-dimethylphenyl)-4-(4-methylphenyl)-;N-(2,6-Dimethylphenyl)-4-(4-methylphenyl)-1,3-thiazol-2-amine
CAS No.730950-31-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZZEG082 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLTQS639 route compound structure diagram
    ACLTQS6396396-76-5 In Stock
  4. Then
  5. ACZZEG082 route product structure diagram
    ACZZEG082730950-31-9
Inquiry

2. ACZZEG082 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIFZV480 route compound structure diagram
    ACIFZV4804209-24-9 In Stock
  2. Plus
  3. ACLTQS639 route compound structure diagram
    ACLTQS6396396-76-5 In Stock
  4. Then
  5. ACZZEG082 route product structure diagram
    ACZZEG082730950-31-9
Inquiry

Comments (0)